HIGHLIGHTS
- who: Lina Straten from the population-based study assessed the risk of SPM development in CLL patients diagnosed during, in the have published the article: Risk of second primary malignancies in patients with chronic lymphocytic leukemia: a population-based study in the Netherlands, 1989-2019, in the Journal: (JOURNAL) of 10/Oct/2022
- what: To complement and extend the currently sparse literature on SPM development in CLL, this nationwide, population-based study aimed to assess temporal trends in SPM development -compared with an age-, sex- and period-matched group of the general population- in various . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.